Navigation Links
NeurogesX Reports First Quarter 2011 Results
Date:4/29/2011

SAN MATEO, Calif., April 29, 2011 /PRNewswire/ --

First Quarter 2011 Highlights:

  • Qutenza® (capsaicin) 8% patch purchased by 321 institutions, up from 239 in Q4 2010
  • Revenue of $3.2 million including $0.6 million U.S. Qutenza product revenue
  • Operational focus enables lower planned expense growth in 2011
  • Qutenza sales initiated in Poland and Czech Republic by Astellas
  • NGX-1998 Phase 2 clinical trial continues in postherpetic neuralgia (PHN) patients surpassing 65% enrollment

  • NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its first quarter ended March 31, 2011.

    Anthony DiTonno, President and CEO, commented, "We are now one full year into the U.S. launch of Qutenza.  We made progress in our goal of creating awareness of Qutenza among our target physician groups and in establishing a base of Qutenza treatment sites from which to build.   As we move into our second year post launch, we are focusing our sales organization on growing the number of sites of care that can optimally utilize Qutenza and building patient awareness and increased physician usage."

    Qutenza Launch MetricsNeurogesX is executing the U.S. launch strategy for Qutenza by establishing a national network of Qutenza referral sites (QPROs) and continuing to expand marketing activities to reach patients treated in the primary care setting.  Key Qutenza launch metrics as of March 31, 2011 were as follows:

  • Qutenza on formulary or available without restriction in 137 institutions as of March 31, 2011, up from 102 at year end 2010
  • 321 institutions purchased Qutenza through first quarter 2011, an increase of 34% from 239 in the fourth quarter 2010
  • Percentage of repeat institutional customers
    '/>"/>

  • SOURCE NeurogesX, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
    2. NeurogesX Reports Fourth Quarter and Year-End 2010 Results
    3. NeurogesX to Provide Qutenza® Launch Update
    4. NeurogesX to Present at Two February Investor Conferences
    5. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
    6. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
    7. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
    8. NeurogesX to Present at Oppenheimer & Co Healthcare Conference
    9. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
    10. NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
    11. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
    (Date:12/22/2014)... , Dec. 22, 2014 Research and ... the addition of the "Investment Analysis of ... to their offering. ... in the US medical device sector identifies the ... and venture capital investments, and mergers and acquisitions. ...
    (Date:12/22/2014)... 2014  Mark Farrah Associates (MFA), www.markfarrah.com ... of the 2015 marketplace exchange projections and insights ... According to a recent ASPE (Office of ... of Health and Human Services) report, an estimated ... plans through the Marketplace as of October 2014 ...
    Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5Investment Analysis of the US Medical Device Sector 2Insights into the Marketplace and Individual Market Growth 2
    ... 5, 2011 CareFusion (NYSE: ... announced Chief Operating Officer Dwight Winstead will leave the company ... COO since CareFusion separated from Cardinal Health on Sept. 1, ... R&D and manufacturing for the company,s business segments. He joined ...
    ... NEW YORK, April 5, 2011 Reportlinker.com announces that ... catalogue: Microscopy Market in Latin America ... Report Description: As of 2009, the ... global microscopy instruments market. This market shows a significant ...
    Cached Medicine Technology:CareFusion Announces Departure of Chief Operating Officer 2Reportlinker Adds Microscopy Market in Latin America 2Reportlinker Adds Microscopy Market in Latin America 3Reportlinker Adds Microscopy Market in Latin America 4Reportlinker Adds Microscopy Market in Latin America 5Reportlinker Adds Microscopy Market in Latin America 6Reportlinker Adds Microscopy Market in Latin America 7
    (Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... can receive effective, less expensive care from a clinic that ... team of dedicated health care professionals, a new study shows. ... need either hospitalization or a trip to the emergency room ... at the University of Texas in Houston versus usual care, ...
    (Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... of youth" drug that can delay the effects of aging ... suggests. Seniors received a significant boost to their immune ... pathway linked to aging and immune function, researchers with the ... a version of the drug rapamycin, improved the seniors, immune ...
    (Date:12/25/2014)... (PRWEB) December 25, 2014 Plugin creators ... ProFire 5k. A fully customizable business presentation tool made ... “Adding the ProFire 5k business tool, users can now ... Austin, CEO of Pixel Film Studios. “ProFire 5k gives ... style to add professionalism to a presentation” , Pixel ...
    (Date:12/24/2014)... AlignLife of Wauwatosa loves helping those in the ... holiday season, AlignLife looks forward to their annual toy drive. ... Mahalko-Leonhardt, owner of AlignLife. "It brings our patients as well ... able to give kids toys for Christmas who would be ... of our patients." , The 70 toys were donated to ...
    (Date:12/24/2014)... December 25, 2014 Recently, iFitDress.com, a famous ... of prom dresses under $150 . All these items are ... company’s website has already been updated with the new range ... been ordered so far. All iFitDress.com’s designs are made according ... on using great materials. Every outfit from the company is ...
    Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2
    ... According to the plans outlined by the Government yesterday, Gay ... children born from fertility// treatment as heterosexual partners - most ... the doctors to consider the "need for a father" before ... a male partner have had difficulty being accepted for the ...
    ... Administration gave the go-ahead for a diagnostic test, to check ... Latin America and the United States’ blood banks that could ... blood banks have seconded this move, and have agreed to ... termed as the Chagas disease. Incidentally, this disease is spread ...
    ... breast cancer cases in 2003.// Researchers have been mulling over ... caught their attention. Nearly millions of women had abandoned hormone ... brought out such a huge difference, is being debated over. ... in the number of breast cancer cases, estimated at 14,000 ...
    ... a ban on sale of Colas and junk food in schools.// ... may be out of school canteens across the country. ... children’s health. Hence, we want to ban the sale of such ... Resource Development Ministry on the legal aspects of the implementation of ...
    ... Kong's Department of Health urges people with history of ... fear a rapid local HIV transmission.// The announcement being ... ,Health officials, on Thursday uncovered two clusters ... analysis of blood samples by government scientists. They said ...
    ... children who are intelligent are more likely to turn ... though researchers are unclear about vegetarianism's link to IQ ... Catharine Gale at England's University of Southampton, studied 8,170 ... edition of health magazine WebMD., ,Participants took an ...
    Cached Medicine News:Health News:Single Women and Lesbians To Enjoy Full Rights in Donor Child Proposals 2
    One splint does it all....
    ... The RCAI Bariatric Knee Immobilizer is made ... stays with a breathable foam material that ... ,The posterior aspect of the splint ... anatomical fit. The loop and lock closure ...
    ... Popliteral Scoring: , One of the outstanding ... is our patented Three-Dimensional Molding Technology. , ... a brace which effectively controls the bunching ... exceptional comfort to the wearer. , ...
    ... might just be the world's most versatile ... support, post-op/rehab support, or both, Flex is ... Accutrac™ ROM hinges control flexion and extension ... durability while being heat-moldable to accommodate changes ...
    Medicine Products: